148 related articles for article (PubMed ID: 10753922)
1. Cell type-specific E2F activation and cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
Ohtani K; Iwanaga R; Arai M; Huang Y; Matsumura Y; Nakamura M
J Biol Chem; 2000 Apr; 275(15):11154-63. PubMed ID: 10753922
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
Iwanaga R; Ohtani K; Hayashi T; Nakamura M
Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
[TBL] [Abstract][Full Text] [Related]
3. Direct trans-activation of the human cyclin D2 gene by the oncogene product Tax of human T-cell leukemia virus type I.
Huang Y; Ohtani K; Iwanaga R; Matsumura Y; Nakamura M
Oncogene; 2001 Mar; 20(9):1094-102. PubMed ID: 11314046
[TBL] [Abstract][Full Text] [Related]
4. Activation of E2F-mediated transcription by human T-cell leukemia virus type I Tax protein in a p16(INK4A)-negative T-cell line.
Lemasson I; Thébault S; Sardet C; Devaux C; Mesnard JM
J Biol Chem; 1998 Sep; 273(36):23598-604. PubMed ID: 9722600
[TBL] [Abstract][Full Text] [Related]
5. Activation of the cyclin D2 and cdk6 genes through NF-kappaB is critical for cell-cycle progression induced by HTLV-I Tax.
Iwanaga R; Ozono E; Fujisawa J; Ikeda MA; Okamura N; Huang Y; Ohtani K
Oncogene; 2008 Sep; 27(42):5635-42. PubMed ID: 18504428
[TBL] [Abstract][Full Text] [Related]
6. High levels of the DNA-binding activity of E2F in adult T-cell leukemia and human T-cell leukemia virus type I-infected cells: possible enhancement of DNA-binding of E2F by the human T-cell leukemia virus I transactivating protein, Tax.
Mori N
Eur J Haematol; 1997 Feb; 58(2):114-20. PubMed ID: 9111593
[TBL] [Abstract][Full Text] [Related]
7. Activation of cyclin D1 and D2 promoters by human T-cell leukemia virus type I tax protein is associated with IL-2-independent growth of T cells.
Mori N; Fujii M; Hinz M; Nakayama K; Yamada Y; Ikeda S; Yamasaki Y; Kashanchi F; Tanaka Y; Tomonaga M; Yamamoto N
Int J Cancer; 2002 May; 99(3):378-85. PubMed ID: 11992406
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the cyclin E gene by transcription factor E2F1.
Ohtani K; DeGregori J; Nevins JR
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12146-50. PubMed ID: 8618861
[TBL] [Abstract][Full Text] [Related]
10. Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 Tax protein.
Mesnard JM; Devaux C
Virology; 1999 May; 257(2):277-84. PubMed ID: 10329537
[No Abstract] [Full Text] [Related]
11. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
12. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
Hiyama H; Iavarone A; LaBaer J; Reeves SA
Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
[TBL] [Abstract][Full Text] [Related]
13. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of specific E2F complexes by the v-mos oncogene.
Afshari CA; Rhodes N; Paules RS; Mudryj M
Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
[TBL] [Abstract][Full Text] [Related]
15. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
Mann DJ; Jones NC
Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
17. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.
Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B
J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262
[TBL] [Abstract][Full Text] [Related]
18. Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-kappaB-like sites.
Mori N; Mukaida N; Ballard DW; Matsushima K; Yamamoto N
Cancer Res; 1998 Sep; 58(17):3993-4000. PubMed ID: 9731513
[TBL] [Abstract][Full Text] [Related]
19. Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.
Good L; Maggirwar SB; Sun SC
EMBO J; 1996 Jul; 15(14):3744-50. PubMed ID: 8670878
[TBL] [Abstract][Full Text] [Related]
20. Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15(INK4B) and p16(INK4A).
Amanullah A; Hoffman B; Liebermann DA
Blood; 2000 Jul; 96(2):475-82. PubMed ID: 10887108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
